Mutagenicity Tests with a Permeable Mutant of Yeast on Carcinogens Showing False-Negative in Salmonella Assay
The mutagenicity (Trp+ reversion) of procarcinogens such as N-nitrosodimethylamine, 3, 4-benzpyrene and 2-acetylaminofluorene has been detected with the permeable mutant of yeast, Saccharomyces cerevisiae C658-K42. The original strain C658, however, showed a positive response only to N-nitrosodimeth...
Saved in:
Published in | Chemical & pharmaceutical bulletin Vol. 37; no. 2; pp. 407 - 409 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Tokyo
The Pharmaceutical Society of Japan
01.02.1989
Maruzen Japan Science and Technology Agency |
Subjects | |
Online Access | Get full text |
ISSN | 0009-2363 1347-5223 |
DOI | 10.1248/cpb.37.407 |
Cover
Summary: | The mutagenicity (Trp+ reversion) of procarcinogens such as N-nitrosodimethylamine, 3, 4-benzpyrene and 2-acetylaminofluorene has been detected with the permeable mutant of yeast, Saccharomyces cerevisiae C658-K42. The original strain C658, however, showed a positive response only to N-nitrosodimethylamine with S9 mix. The permeable mutant C658-K42 was employed for mutagenicity tests on 12 carcinogens which had been reported to be non-mutagenic in Salmonella/microsome tests. It was found that phenobarbital, thiourea, 1, 2-dimethylhydrazine and 4-aminoantipyrine were mutagenic in the presence of S9 mix, Benzene, o-toluidine and thioacetamide were weakly mutagenic. Negative results were obtained for diethylstilbestrol, safrole, acetamide, urethane and ethionine at the concentrations used. Caprolactam did not show any mutagenic effect on C658-K42 at concentrations up to 20 mg/ml. Sodium azide, which is unlikely to be carcinogenic but is strongly mutagenic in the Ames test, showed a very weak mutagenic effect on C658-K42. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
ISSN: | 0009-2363 1347-5223 |
DOI: | 10.1248/cpb.37.407 |